Our results reveal the existence of an important subpopulation of MM cells expressing functional E-selectin ligands, which appear to be enriched at relapse, implicate E-selectin binding in Bortezomib resistance in vivo and demonstrate the potential of a small molecule E-selectin inhibitor GMI-1271 to overcome this resistance. The gene discussed is SELE; the disease is Miyoshi myopathy.